Università Vita-Salute San Raffaele and IRCCS San Raffaele Scientific Institute, Milan, Italy, Massachusetts General Hospital, Boston, Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, Massachusetts.
Università Vita-Salute San Raffaele and IRCCS San Raffaele Scientific Institute, Milan, Italy.
Arthritis Rheumatol. 2018 Jul;70(7):1133-1143. doi: 10.1002/art.40469. Epub 2018 May 20.
An unconventional population of CD4+ signaling lymphocytic activation molecule family member 7-positive (SLAMF7+) cytotoxic effector memory T (T ) cells (CD4+ cytotoxic T lymphocytes [CTLs]) has been linked causally to IgG4-related disease (IgG4-RD). Glucocorticoids represent the first-line therapeutic approach in patients with IgG4-RD, but their mechanism of action in this specific condition remains unknown. We undertook this study to determine the impact of glucocorticoids on CD4+ CTLs in IgG4-RD.
Expression of CD8α, granzyme A, perforin, and SLAMF7 within the effector memory compartment of CD45RO+ (T ) and CD45RA+ effector memory T (T ) CD4+ cells was quantified by flow cytometry in 18 patients with active IgG4-RD, both at baseline and after 6 months of glucocorticoid treatment. Eighteen healthy subjects were studied as controls. Next-generation sequencing of the T cell receptor α- and β-chain gene was performed on circulating CD4+ CTLs from patients with IgG4-RD before and after treatment and in affected tissues.
Circulating CD4+ T and T cells were not expanded in IgG4-RD patients compared to healthy controls. CD4+SLAMF7+ T cells (but not T cells) were significantly increased among IgG4-RD patients. Within CD4+SLAMF7+ T cells, CD8α- cells but not CD8α cells were elevated in IgG4-RD patients. The same dominant clones of CD8α-CD4+SLAMF7+ T cells found in peripheral blood were also identified in affected tissue. CD8α- and CD8α CD4+SLAMF7+ T cells both expressed cytolytic molecules. Clonally expanded CD8α- but not CD8α CD4+SLAMF7+ T cells decreased following glucocorticoid-induced disease remission.
A subset of CD8α-CD4+SLAMF7+ cytotoxic T cells is oligoclonally expanded in patients with active IgG4-RD. This T cell population contracts following glucocorticoid-induced remission. Further characterization of this cell population may provide prognostic information and targets for therapeutic intervention.
CD4+信号淋巴细胞激活分子家族成员 7 阳性(SLAMF7+)细胞毒性效应记忆 T(T)细胞(CD4+细胞毒性 T 淋巴细胞[CTL])的非常规群体与 IgG4 相关疾病(IgG4-RD)有因果关系。糖皮质激素是 IgG4-RD 患者的一线治疗方法,但在这种特定情况下,其作用机制尚不清楚。我们进行这项研究是为了确定糖皮质激素对 IgG4-RD 中 CD4+CTL 的影响。
通过流式细胞术,在 18 例活动性 IgG4-RD 患者和 18 例健康对照者的 CD45RO+(T)和 CD45RA+效应记忆 T(T)CD4+细胞的效应记忆区中,定量检测 CD8α、颗粒酶 A、穿孔素和 SLAMF7 的表达。18 例健康受试者作为对照进行研究。对 IgG4-RD 患者治疗前后及受累组织中循环 CD4+CTL 的 T 细胞受体α-和β链基因进行下一代测序。
与健康对照组相比,IgG4-RD 患者的循环 CD4+T 和 T 细胞并未扩增。IgG4-RD 患者中 CD4+SLAMF7+T 细胞(而非 T 细胞)显著增加。在 CD4+SLAMF7+T 细胞中,CD8α-CD4+SLAMF7+T 细胞升高,而 CD8α+细胞则不然。在外周血中发现的 CD8α-CD4+SLAMF7+T 细胞的相同优势克隆也在受累组织中被鉴定出来。CD8α-和 CD8α+CD4+SLAMF7+T 细胞均表达细胞毒性分子。克隆扩增的 CD8α-而非 CD8α+CD4+SLAMF7+T 细胞在糖皮质激素诱导疾病缓解后减少。
在活动性 IgG4-RD 患者中,CD8α-CD4+SLAMF7+细胞毒性 T 细胞的一个亚群呈寡克隆扩增。该 T 细胞群在糖皮质激素诱导缓解后收缩。对该细胞群的进一步特征描述可能提供预后信息和治疗干预靶点。